Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia Moderate”

500 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 500 results

Testing effectiveness (Phase 2)Study completedNCT01782742
What this trial is testing

Bexarotene Amyloid Treatment for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
The Cleveland Clinic 20
Testing effectiveness (Phase 2)Study completedNCT04388254
What this trial is testing

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 220
Early research (Phase 1)Study completedNCT05466422
What this trial is testing

MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)

Who this might be right for
Alzheimer Disease
Merck Sharp & Dohme LLC 34
Post-approval studies (Phase 4)Study completedNCT02097056
What this trial is testing

Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Korea Inc. 171
Not applicableStudy completedNCT01825317
What this trial is testing

Effect of NeuroAD on Alzheimer Patients

Who this might be right for
Alzheimer's Disease
Neuronix Ltd 32
Testing effectiveness (Phase 2)UnknownNCT04780399
What this trial is testing

Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseYangxue Qingnao PillsRandomized
Dongzhimen Hospital, Beijing 216
Testing effectiveness (Phase 2)Study completedNCT02279511
What this trial is testing

ATP in Alzheimer Disease

Who this might be right for
Alzheimer's Disease
Sara Varea 20
Testing effectiveness (Phase 2)UnknownNCT01120002
What this trial is testing

Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Osaka City University 50
Not applicableLooking for participantsNCT06584357
What this trial is testing

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more
GAP Innovations, PBC 1,200
Not applicableStudy completedNCT04008342
What this trial is testing

Multisensory Stimulation in Dementia.

Who this might be right for
Dementia
Federal University of Minas Gerais 60
Post-approval studies (Phase 4)Study completedNCT01122329
What this trial is testing

A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
University of California, Los Angeles 17
Early research (Phase 1)Study completedNCT01125631
What this trial is testing

Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 8
Testing effectiveness (Phase 2)Ended earlyNCT00299988
What this trial is testing

Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Weill Medical College of Cornell University 24
Testing effectiveness (Phase 2)Study completedNCT01735630
What this trial is testing

Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 350
Testing effectiveness (Phase 2)Study completedNCT00359944
What this trial is testing

Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sumitomo Pharma America, Inc. 171
Testing effectiveness (Phase 2)Ended earlyNCT05478031
What this trial is testing

A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
reMYND 14
Not applicableStudy completedNCT05637801
What this trial is testing

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+32 more
Cognito Therapeutics, Inc. 673
Testing effectiveness (Phase 2)Looking for participantsNCT07058688
What this trial is testing

NTRX-07 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
NeuroTherapia, Inc. 48
Testing effectiveness (Phase 2)Ended earlyNCT02249351
What this trial is testing

Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 54
Not applicableStudy completedNCT05860127
What this trial is testing

Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial

Who this might be right for
DementiaCognitive Impairment, MildDementia, Vascular+6 more
University of Massachusetts, Amherst 133
Next Page